Dermatologicals in the Philippines
DERMATOLOGICALS IN THE PHILIPPINES
Euromonitor International
February 2019
LIST OF CONTENTS AND TABLES
Headlines
Prospects
Paediatric Dermatologicals Is A Possible Growth Opportunity
Stigma for Some Dermatologicals, But Room for Growth
Higher Awareness of Eczema and Proactive Parents Boost the Growth of Antipruritics
Competitive Landscape
the Leading Brand in Dermatologicals Is Local Brand Novuhair From Nutramedica
Johnson & Johnson (philippines) Leads Dermatologicals
Opportunities for Companies in Haemorrhoid Treatments and Vaginal Antifungals
Category Data
Table 1 Sales of Dermatologicals by Category: Value 2013-2018
Table 2 Sales of Dermatologicals by Category: % Value Growth 2013-2018
Table 3 NBO Company Shares of Dermatologicals: % Value 2014-2018
Table 4 LBN Brand Shares of Dermatologicals: % Value 2015-2018
Table 5 LBN Brand Shares of Hair Loss Treatments: % Value 2015-2018
Table 6 Forecast Sales of Dermatologicals by Category: Value 2018-2023
Table 7 Forecast Sales of Dermatologicals by Category: % Value Growth 2018-2023
Executive Summary
Consumer Health Remains A Priority Despite the Unstable Economic Conditions
Healthier Lifestyles and Dynamic Millennials Offset Higher Inflation
the Leading Players Drive Growth Through An Increasing Presence in Retail Channels
Internet Retailing Increases As More Players Aim To Become More Visible
Stable But Stagnant Growth Expected for Consumer Health
Market Indicators
Table 8 Consumer Expenditure on Health Goods and Medical Services: Value 2013-2018
Table 9 Life Expectancy at Birth 2013-2018
Market Data
Table 10 Sales of Consumer Health by Category: Value 2013-2018
Table 11 Sales of Consumer Health by Category: % Value Growth 2013-2018
Table 12 NBO Company Shares of Consumer Health: % Value 2014-2018
Table 13 LBN Brand Shares of Consumer Health: % Value 2015-2018
Table 14 Distribution of Consumer Health by Format: % Value 2013-2018
Table 15 Distribution of Consumer Health by Format and Category: % Value 2018
Table 16 Forecast Sales of Consumer Health by Category: Value 2018-2023
Table 17 Forecast Sales of Consumer Health by Category: % Value Growth 2018-2023
Appendix
OTC Registration and Classification
Vitamins and Dietary Supplements Registration and Classification
Self-medication/self-care and Preventive Medicine
Switches
Definitions
Sources
Summary 1 Research Sources
The success story of the Elica brand in recent years, through its marketing as being suitable for children, reflects an interesting opportunity for dermatologicals. Over the years, companies have provided dermatologicals for children only in nappy (diaper) rash treatments, and might be missing an opportunity to take advantage of other categories. The increasing population of young parents paves the way for opportunities in paediatric dermatologicals. With steadily growing incomes, young parents...
Euromonitor International's Dermatologicals in Philippines report offers a comprehensive guide to the size and shape of the market at a national level. It provides the latest retail sales data 2014-2018, allowing you to identify the sectors driving growth. Forecasts to 2023 illustrate how the market is set to change.
Product coverage: Antiparasitics/Lice (Head and Body) Treatments, Antipruritics, Cold Sore Treatments, Haemorrhoid Treatments, Hair Loss Treatments, Medicated Shampoos, Nappy (Diaper) Rash Treatments, Paediatric Dermatologicals, Topical Allergy Remedies/Antihistamines, Topical Antifungals, Topical Germicidals/Antiseptics, Vaginal Antifungals.
Data coverage: market sizes (historic and forecasts), company shares, brand shares and distribution data.
Why buy this report?
* Get a detailed picture of the Dermatologicals market;
* Pinpoint growth sectors and identify factors driving change;
* Understand the competitive environment, the market’s major players and leading brands;
* Use five-year forecasts to assess how the market is predicted to develop.
Euromonitor International has over 40 years' experience of publishing market research reports, business reference books and online information systems. With offices in London, Chicago, Singapore, Shanghai, Vilnius, Dubai, Cape Town, Santiago, Sydney, Tokyo and Bangalore and a network of over 800 analysts worldwide, Euromonitor International has a unique capability to develop reliable information resources to help drive informed strategic planning.